[go: up one dir, main page]

WO1997032593A3 - Composition containing iso-flavonoids and lignans - Google Patents

Composition containing iso-flavonoids and lignans Download PDF

Info

Publication number
WO1997032593A3
WO1997032593A3 PCT/GB1997/000622 GB9700622W WO9732593A3 WO 1997032593 A3 WO1997032593 A3 WO 1997032593A3 GB 9700622 W GB9700622 W GB 9700622W WO 9732593 A3 WO9732593 A3 WO 9732593A3
Authority
WO
WIPO (PCT)
Prior art keywords
lignans
flavonoids
composition
component
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1997/000622
Other languages
French (fr)
Other versions
WO1997032593A2 (en
Inventor
Michael Stafford Morton
Keith Griffiths
Carl Herman Thoma Adler-Creutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Energiser PLC
Original Assignee
Energiser PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604945.7A external-priority patent/GB9604945D0/en
Priority claimed from GBGB9610768.5A external-priority patent/GB9610768D0/en
Application filed by Energiser PLC filed Critical Energiser PLC
Priority to AU21009/97A priority Critical patent/AU2100997A/en
Publication of WO1997032593A2 publication Critical patent/WO1997032593A2/en
Publication of WO1997032593A3 publication Critical patent/WO1997032593A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

There is provided a composition and method of treatment useful to combat disease states, such as cancer, especially before such disease states are clinically detectable or alternatively when they are less advanced. The composition is capable of elevating the levels of iso-flavonoids (e.g. genistein) and lignans (e.g. enterolactone) in the body to therapeutically useful levels. Conveniently the composition of the present invention is presented in the form of a foodstuff, conveniently in the form of a biscuit or 'cookie' and contains a soya component, together with a flaxseed component and/or a rye component.
PCT/GB1997/000622 1996-03-08 1997-03-10 Composition containing iso-flavonoids and lignans Ceased WO1997032593A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU21009/97A AU2100997A (en) 1996-03-08 1997-03-10 Composition containing iso-flavonoids and lignans

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9604945.7 1996-03-08
GBGB9604945.7A GB9604945D0 (en) 1996-03-08 1996-03-08 Composition
GBGB9610768.5A GB9610768D0 (en) 1996-05-23 1996-05-23 Composition
GB9610768.5 1996-05-23

Publications (2)

Publication Number Publication Date
WO1997032593A2 WO1997032593A2 (en) 1997-09-12
WO1997032593A3 true WO1997032593A3 (en) 1997-10-30

Family

ID=26308892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000622 Ceased WO1997032593A2 (en) 1996-03-08 1997-03-10 Composition containing iso-flavonoids and lignans

Country Status (2)

Country Link
AU (1) AU2100997A (en)
WO (1) WO1997032593A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391310B1 (en) 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
EP0954984A1 (en) * 1998-05-04 1999-11-10 Källna Specialprodukter AB Dietary fibre composition
US6689809B2 (en) 1999-03-30 2004-02-10 Hormos Nutraceutical Oy Ltd. Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
US6451849B1 (en) 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
FI115192B (en) * 2001-02-26 2005-03-31 Oriola Oy Functional food and process for making this
FI120901B (en) * 2004-08-25 2010-04-30 Oriola Oy Functional food and its use
BRPI0519851A2 (en) * 2005-01-10 2017-05-30 Hormos Medical Ltd use of a lignan to manufacture a composition to prevent or alleviate symptoms related to estrogen deficiency
ITPI20110034A1 (en) 2011-04-01 2012-10-02 Funcional Food Res S R L FUNCTIONAL FOOD PREPARATION FOR FEMALE USE.
CN108208076A (en) * 2018-01-09 2018-06-29 广州聚澜健康产业研究院有限公司 A kind of chocolate souffles and preparation method thereof
KR20230055262A (en) * 2021-10-18 2023-04-25 리누 바이오 헬스 엘티디. Composition for the prevention and treatment of female menopausal disease comprising phytogen as active ingredients

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001905A1 (en) * 1990-01-24 1991-07-25 Wilhelm Menge Mfr. of bakery prods. - from mixt. of cereal materials and pressed oil seeds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001905A1 (en) * 1990-01-24 1991-07-25 Wilhelm Menge Mfr. of bakery prods. - from mixt. of cereal materials and pressed oil seeds

Also Published As

Publication number Publication date
WO1997032593A2 (en) 1997-09-12
AU2100997A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
EP1273298A3 (en) Ritonavir in combination with an additional HIV protease inhibitor for treating aids
WO1996005838A3 (en) Combined preparation for the therapy of immune diseases
WO2002056912A3 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
EP1040827A3 (en) Use of 2-alkylpyrrolidines for the treatment of diabetes
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
WO1997032593A3 (en) Composition containing iso-flavonoids and lignans
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
WO1998001440A3 (en) Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
CA2019812A1 (en) Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
WO1999009964A3 (en) Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections
CA2139385A1 (en) Products containing g-csf and tnf binding protein
CA2412789A1 (en) Compositions for improving mental concentration
AU2001287850A1 (en) Iron compositions
WO1996041627A3 (en) Iron compounds, compositions, methods of making the same and uses thereof
WO2003045324A3 (en) 14-methyl-epothilones
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
CA2270423A1 (en) Prophylactic/therapeutic agent
WO1996021468A3 (en) Chemically modified interferon
CA2063273A1 (en) Surfactant compositions and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1997906264

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWW Wipo information: withdrawn in national office

Ref document number: 1997906264

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97531581

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase